Actinogen Medical Ltd has released a press release.
Actinogen appoints XanaFX Phase 2 trial manager
Filed with ASX ·
6ix hasn’t read this filing yet.
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Actinogen Medical: ACW CEO Presents at San Francisco Healthcare Conference
- Capital Raising Completion
- ACW Strategic Collaboration with Oxford Uni Researchers
- XanaMIA Part A trial achieves target enrolment
- Strategic Update & Capital Raising Investor Presentation
Later from Actinogen Medical
- Actinogen XanaMIA Part A trial results expected in April
- Appendix 4D & Half-Year Financial Statements
- Actinogen Medical: ACW CEO Presents at European Life Sciences Conference
- Letter to Shareholders & Notice of General Meeting
- ACW announces positive XanaMIA results for Xanamem
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical